RNF128 and metabolic dysfunction-associated steatotic liver disease: First, we analyzed the Grail expression of liver samples from with NAFLD and normal patients by immunohistochemistry and found that expression of Grail was obviously increased in fatty liver patients (Fig. 1A, B).